First Time Loading...

Exelixis Inc
NASDAQ:EXEL

Watchlist Manager
Exelixis Inc Logo
Exelixis Inc
NASDAQ:EXEL
Watchlist
Price: 23.7 USD 0.72% Market Closed
Updated: Apr 29, 2024

Exelixis Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exelixis Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Exelixis Inc
NASDAQ:EXEL
Cash from Financing Activities
-$546.1m
CAGR 3-Years
-179%
CAGR 5-Years
N/A
CAGR 10-Years
-47%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Exelixis Inc's Cash from Financing Activities?
Cash from Financing Activities
-546.1m USD

Based on the financial report for Dec 29, 2023, Exelixis Inc's Cash from Financing Activities amounts to -546.1m USD.

What is Exelixis Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-47%

The average annual Cash from Financing Activities growth rates for Exelixis Inc have been -179% over the past three years , and -47% over the past ten years .